EP0000988A1 - Demand cardiac stimulating apparatus - Google Patents
Demand cardiac stimulating apparatus Download PDFInfo
- Publication number
- EP0000988A1 EP0000988A1 EP78300242A EP78300242A EP0000988A1 EP 0000988 A1 EP0000988 A1 EP 0000988A1 EP 78300242 A EP78300242 A EP 78300242A EP 78300242 A EP78300242 A EP 78300242A EP 0000988 A1 EP0000988 A1 EP 0000988A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- counter
- reset
- input
- flop
- control means
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
Definitions
- a demand pacemaker normally includes an input amplifier for receiving and amplifying electrical signals from the heart (which signals might result from either a natural beat or an artificial pulse which has just been generated by the pacemaker), a pacemaker control circuitry which receives the amplified signals and which causes a new artificial stimulating pulse to be generated (for transmission to the heart) only if the amplified signals, or lack thereof, show that an artificial stimulating pulse is required by the heart (i.e. on demand), and an output amplifier which receives and amplifies the artificial pulses generated by the control circuitry, for passage to the heart.
- a single input pulse is received during the last 88-96 msec of the refractory period, this effectively acts to extend the refractory period by up to 96 msec maximum, to provide a "system refractory period" of 416 msec maximum.
- This "refractory period extension" may be beneficial to the pacemaker in that extraneous signals present towards the latter part of the refractory period are ignored (as being natural heart beats) and the chance of the pacemaker being inhibited by unwanted signals (e.g. a large T-wave from the heart) is reduced.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
Description
- This invention relates to implantable body function control apparatus and particularly, but not exclusively, to body tissue stimulating devices such as cardiac pacemakers.
- Pacemakers for generating artificial stimulating pulses for the heart, and which may or may not be implanted in the body, are well-known. Pacemakers can be classified into demand and non-demand types. A demand pacemaker only issues an artificial pulse if the heart does not produce its own satisfactory natural beat, whereas a non-demand pacemaker issues artificial stimulating pulses without regard to the presence or absence of a natural beat.
- A demand pacemaker normally includes an input amplifier for receiving and amplifying electrical signals from the heart (which signals might result from either a natural beat or an artificial pulse which has just been generated by the pacemaker), a pacemaker control circuitry which receives the amplified signals and which causes a new artificial stimulating pulse to be generated (for transmission to the heart) only if the amplified signals, or lack thereof, show that an artificial stimulating pulse is required by the heart (i.e. on demand), and an output amplifier which receives and amplifies the artificial pulses generated by the control circuitry, for passage to the heart.
- Many types of pacemaker control circuitry as described above are available. Some function on an analog basis to produce the accurately-timed artificial stimulating pulses, whereas several recent designs employ digital circuitry.
- With demand pacemakers, it is highly desirable to provide protection for the input circuitry from noise. Should a person bearing an implanted demand pacemaker meet an environment of high electrical noise, this noise may be picked up by the input amplifier which may then be incapable of distinguishing the picked-up signals from the signals it normally receives from the heart. In such circumstances, the circuitry is likely to consider the noise signals in the same manner as if it had received signals arising from a natural heart beat - it will operate in its usual demand mode by not issuing artificial stimulating pulses to the heart. Since the heart may not be operating normally, and may indeed require artificial stimulation, these noise signals preventing such stimulation can lead to a dangerous condition for the person concerned.
- Noise protection circuits have been incorporated into demand pacemakers in the past. For example, several include filters to attenuate noise signals of particular frequencies (particularly the commercial power mains frequency).
- We have now developed a novel noise detection circuit for use in protecting demand pacemakers and which can be efficiently constructed with a small number of components of digital function. This is particularly useful in that it enables the components to be included in an integrated pacemaker circuit, e.g. of MSI or LSI construction.
- According to the invention there is provided an implantable, body tissue stimulating apparatus comprising means for providing electrical signals for artificially stimulating body tissue upon demand, said providing means including an input amplifier for receiving input signals from the body for controlling the demand status of the apparatus, means responsive to signals from the input amplifier for distinguishing whether one or more input signals are received by said input amplifier within a predetermined period of time, and demand status control means responsive to said distinguishing means for enabling the providing means to function in its demand mode if only one input signal is received within said predetermined period of time and for causing the providing means to function in a non-demand mode if more than one input signal is received within said predetermined period of time. Brief Description of the Drawings
- Preferred features of the invention are illustrated in the accompanying drawings, in which:
- Figure 1 shows a schematic electrical circuit diagram of an implantable, demand fixed-rate cardiac pacemaker according to the invention, and
- Figure 2 is a timing diagram for use with Figure 1.
- Referring to Figure 1, the pacemaker comprises an
oscillator 1 which clocks aripple counter 2. A cardiac stimulating pulse rate is obtained from an appropriate output stage, Q, ofcounter 2 and is provided to anoutput amplifier 3 and to one input of an OR gate 4. Theoutput amplifier 3 provides amplified tissue stimulating pulses to a connection 5 for coupling to an electrode leading to the heart. The output of OR gate 4 is supplied to a monostable 6, which is employed to resetcounter 2. - The pacemaker also includes an
input amplifier 8 which receives electrical signals generated at the heart (e.g. arising from natural heart beats) and supplies these signals, amplified, to the reset input of aripple counter 9. - Two of the output stages of
counter 9, nominated Q3 and Q4, provide inputs to aNAND gate 10, the output of which supplies the clock input to a D-type flip-flop 11 and an input to aNAND gate 12. The latter clocks ripplecounter 9. - The Q output of flip-
flop 11 supplies a second input to OR gate 4, and the D-input of flip-flop 11 is tied to the positive supply rail. - A further D-type flip-
flop 13 is provided which is reset from the output of monostable 6 and whose Q output is employed to reset flip-flop 11. The D-input of flip-flop 13 is tied to the positive supply rail. - The
counter 2 also supplies two clock outputs, CK1 and CK2. CK1, having a period of 8 msecs, is employed to provide a second input toNAND gate 12, and CK2 is employed to clock flip-flop 13. The clock pulse CK2 arises 320 msecs aftercounter 2 is reset. - The pacemaker operates as follows. In its fixed rate mode, with neither noise nor natural heart beats being detected and amplified by
input amplifier 8, counter 2 issues a continuous series of tissue stimulating pulses tooutput amplifier 3. The reset forcounter 2 after each pulse occurs via OR gate 4, and monostable 6. Thecounter 2 is reset on the trailing edge of the monostable pulse and the firing time of the latter thus determines the pulse width of each stimulating pulse issued bycounter 2. - Each reset pulse provided by monostable 6 also resets flip-
flop 13, holding its Q output high. This reset holds until flip-flop 13 is clocked by a clock pulse CK2. Until this clocking occurs, the Q output of flip-flop 13 holds a reset on flip-flop 11. The purpose of flip-flop 13 is to create a refractory period of 320 msecs - a period of time after a pacemaker pulse or a natural beat during which any input to the pacemaker viainput amplifier 8 has no effect on the pacemaker behavior. - The purpose of
counter 9, flip-flop 11 and associated circuitry is to allow a single pulse at theinput amplifier 8 to resetcounter 2 if the pulse occurs outside the refractory period. In such a circumstance, the pacemaker acts in a normal demand mode - only issuing pacemaker pulses if a natural beat is missing. - For explanation of the normal demand mode operation, assume initially that
counter 2 has-issued a pulse to cause itself to reset via OR gate 4. This reset will have reset flip-flop 13 and this, via the Q output of the latter, will also reset flip-flop 11. The Q output of flip-flop 11 will be low. Assume also thatcounter 9 is full, in the sense that the Q3, Q4 stages are high. This will cause point "A" to be low, and the output ofNAND gate 12 to be high, thus locking out further CK- clock pulses to counter 9. -
Counter 2 recommences counting and until the count CK2 is reached, the reset on flip-flop 11 will be held. On reaching CK2, flip-flop 13 clocks.-and its Q output goes low, removing the flip-flop 11 reset. This is the end of the refractory period. Sincecounter 9 is locked out, and point "A" is locked low, flip-flop 11 is not clocked and its Q output remains low. - If a single input pulse is received by
amplifier 8 after the end of the refractory period (i.e. as a result of a natural heart beat),counter 9 is reset, Q3 and Q4 go low, and the point "A" goes high to clock flip-flop 11. The Q output of the latter resetscounter 2 via OR gate 4 to inhibit the pacemaker pulse being generated, and recommences the refractory period by resetting flip-flop 13.Counter 9, in the meantime, commences counting clock pulses CK1 and locks out again when Q3, Q4 go high. It is of no consequence if the reset tocounter 2 initiated by a natural heart beat arrives just as an artificial pulse is generated, since the natural beat and the stimulating pulse will essentially coincide. - If a series of input pulses are received having an interpulse period less than 88 msecs,
counter 9 is continuously reset and, apart from the initial reset on-the first of these pulses, point "A" does not make the low to high transition necessary to clock flip-flop 11. When this occurs, flip-flop 11 is then incapable of continuously resettingcounter 2 and the pacemaker reverts to the fixed rate mode described above. The effect of the noise detection circuitry is hence to cause the pacemaker to operate in its fixed rate non-demand mode in the presence of noise (or heart generated signals) having a period less than 88 msec, This figure of 88 msec arises in that it is the minimum time required to fill counter 9 (i.e. Q3 and Q4 high) after a first input pulse is received viaamplifier 8 to resetcounter 9. The maximum time required to fillcounter 9 is 96 msec. The spread of 88 to 96 msec (1 clock period) is due to the asynchronous nature of the incoming signal toamplifier 8 compared to the next occurrence of a CK1 clock pulse. - If a single input pulse is received during the last 88-96 msec of the refractory period, this effectively acts to extend the refractory period by up to 96 msec maximum, to provide a "system refractory period" of 416 msec maximum. This "refractory period extension" may be beneficial to the pacemaker in that extraneous signals present towards the latter part of the refractory period are ignored (as being natural heart beats) and the chance of the pacemaker being inhibited by unwanted signals (e.g. a large T-wave from the heart) is reduced.
- This phenomenon of "refractory period extension" is best understood with reference to the timing diagram of Figure 2. A reset to counter 9 arises towards the end of the refractory period and this sends the point "A" (clock input to flip-flop 11) high. The period for which "A" remains high after the refractory period of 320 msec expires (a maximum of 96 msecs) acts as a "refractory period extension" any input to
amplifier 8 causing a reset oncounter 9 during this extended period (the "system refractory period") will not inhibit the count being generated by thecounter 2.
Claims (3)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3491477 | 1977-08-19 | ||
GB3491477 | 1977-08-19 | ||
US917129 | 1978-06-19 | ||
US05/917,129 US4173230A (en) | 1977-08-19 | 1978-06-19 | Noise elimination and refractory period control in demand pacers |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0000988A1 true EP0000988A1 (en) | 1979-03-07 |
EP0000988B1 EP0000988B1 (en) | 1982-05-26 |
Family
ID=26262490
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19780300242 Expired EP0000988B1 (en) | 1977-08-19 | 1978-08-03 | Demand cardiac stimulating apparatus |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0000988B1 (en) |
AU (1) | AU3895978A (en) |
CA (1) | CA1098589A (en) |
DE (1) | DE2861865D1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2440198A1 (en) * | 1978-11-06 | 1980-05-30 | Medtronic Inc | IMPLANTABLE STIMULATOR |
EP0011939A2 (en) * | 1978-11-06 | 1980-06-11 | Medtronic, Inc. | Digital cardiac pacemaker pulse generator |
EP0011938A2 (en) * | 1978-11-06 | 1980-06-11 | Medtronic, Inc. | Programmable cardiac pacemaker pulse generator |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3557796A (en) * | 1969-03-10 | 1971-01-26 | Cordis Corp | Digital counter driven pacer |
FR2329007A1 (en) * | 1975-10-23 | 1977-05-20 | Arco Med Prod Co | DIGITAL HEART STIMULATOR |
LU76880A1 (en) * | 1976-03-03 | 1977-07-12 |
-
1978
- 1978-08-03 DE DE7878300242T patent/DE2861865D1/en not_active Expired
- 1978-08-03 EP EP19780300242 patent/EP0000988B1/en not_active Expired
- 1978-08-16 AU AU38959/78A patent/AU3895978A/en active Pending
- 1978-08-17 CA CA309,560A patent/CA1098589A/en not_active Expired
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3557796A (en) * | 1969-03-10 | 1971-01-26 | Cordis Corp | Digital counter driven pacer |
FR2329007A1 (en) * | 1975-10-23 | 1977-05-20 | Arco Med Prod Co | DIGITAL HEART STIMULATOR |
LU76880A1 (en) * | 1976-03-03 | 1977-07-12 |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2440198A1 (en) * | 1978-11-06 | 1980-05-30 | Medtronic Inc | IMPLANTABLE STIMULATOR |
EP0011939A2 (en) * | 1978-11-06 | 1980-06-11 | Medtronic, Inc. | Digital cardiac pacemaker pulse generator |
EP0011938A2 (en) * | 1978-11-06 | 1980-06-11 | Medtronic, Inc. | Programmable cardiac pacemaker pulse generator |
FR2443845A1 (en) * | 1978-11-06 | 1980-07-11 | Medtronic Inc | IMPROVED DIGITAL HEART STIMULATOR PULSE GENERATOR |
EP0011938A3 (en) * | 1978-11-06 | 1981-01-07 | Medtronic, Inc. | Programmable cardiac pacemaker pulse generator |
EP0011939A3 (en) * | 1978-11-06 | 1981-01-07 | Medtronic, Inc. | Digital cardiac pacemaker pulse generator |
Also Published As
Publication number | Publication date |
---|---|
AU3895978A (en) | 1980-02-21 |
EP0000988B1 (en) | 1982-05-26 |
CA1098589A (en) | 1981-03-31 |
DE2861865D1 (en) | 1982-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4407287A (en) | Atrial and ventricular-only pacemaker responsive to premature ventricular contractions | |
US3949758A (en) | Automatic threshold following cardiac pacer | |
US4408606A (en) | Rate related tachycardia control pacer | |
US4401119A (en) | Prolongation of timing intervals in response to ectopic heart beats in atrial and ventricular pacemakers | |
DE69114165T2 (en) | Pacemaker with means to prevent false responses to premature ventricular contractions. | |
US5137022A (en) | Synchronous telemetry system and method for an implantable medical device | |
US4173230A (en) | Noise elimination and refractory period control in demand pacers | |
US4649931A (en) | Sampled data sense amplifier | |
US3661157A (en) | Inhibited demand pacer with a two-rate pulse generator | |
US4043347A (en) | Multiple-function demand pacer with low current drain | |
US4304238A (en) | Programmable demand pacer | |
GB2048688A (en) | Programmable demand pacer | |
EP0050038A2 (en) | Heart pacemaker with separate A-V intervals for atrial synchronous and atrial-ventricular sequential pacing modes | |
US3757791A (en) | Synchronized atrial and ventricular pacer and timing circuitry therefor | |
US4802483A (en) | Heart pacemaker for avoiding pacemaker mediated tachycardia at mode switching | |
GB1578633A (en) | Cardiac pacemaker | |
CA1106450A (en) | Digital cardiac pacer with refractory count inhibition | |
EP0000988A1 (en) | Demand cardiac stimulating apparatus | |
US4466440A (en) | Heart pacer time-domain processing of internal physiological signals | |
US4164945A (en) | Digital cardiac pacemaker medical device | |
EP0308535B1 (en) | Pacemaker having pvc response and pmt terminating features | |
US5052389A (en) | Low-power A/D converter for an implantable medical device and method of use | |
US3949759A (en) | Cardiac pacing apparatus | |
CA1098590A (en) | Demand pacer having reduced recovery time | |
US4049003A (en) | Digital cardiac pacer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Designated state(s): DE FR GB NL SE |
|
17P | Request for examination filed | ||
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Designated state(s): DE FR GB NL SE |
|
REF | Corresponds to: |
Ref document number: 2861865 Country of ref document: DE Date of ref document: 19820715 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 19830731 Year of fee payment: 6 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Effective date: 19840804 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 19840828 Year of fee payment: 7 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee | ||
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 19860831 Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Effective date: 19880301 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19880429 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19881117 |
|
EUG | Se: european patent has lapsed |
Ref document number: 78300242.1 Effective date: 19850612 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 19971028 Year of fee payment: 20 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |